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Background and Purpose 
An accompanying brief indicates that illicit drug use disorders are no longer a strictly metropolitan phenomenon 
and that heroin use disorder prevalence rates have risen among non-metropolitan adults ages 18-64 in recent 
years.1  Yet, a dearth of research has investigated treatment access among rural illicit drug users.  A review of 
past studies on rural treatment access found that most lacked national generalizability because they relied on 
treatment-based samples, noting that most persons with an illicit drug use disorder never seek treatment, or 
relied on small cohorts.2 
Perceived need for treatment represents recognition of a drug use problem and thinking that obtaining formal 
services could be beneficial, and it has been shown to be a strong precursor to actual treatment utilization.3-5  In 
a study of 2008-2012 data from the National Survey on Drug Use and Health (NSDUH), perceived treatment 
need was found to be strongly associated with substance use treatment utilization among persons with private 
insurance relative to those who did not feel a need for treatment and had no insurance.6  Its authors and other 
investigators have argued for further development of programs and policies to elevate public perceptions of the 
benefits of treatment to facilitate perceptions of treatment need and eventual treatment use.6,7 
This report examines metropolitan versus non-metropolitan differences and temporal changes in prevalence 
rates for past year perceived need for treatment and treatment utilization among adults ages 18-64 with a past 
year illicit drug use disorder (any type of illicit drug, opioid, heroin, and prescription pain reliever use 
disorders). 
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Overview of Key Findings  
The policy brief provides nationally representative estimates of perceived treatment need and utilization 
for illicit drug and prescription pain reliever use disorders among non-metropolitan and metropolitan 
adults ages 18-64.  Rates of perceived treatment need and utilization were low among non-metropolitan 
(rural) residents with past year drug use disorders in 2014-2015 as highlighted below: 
 
Drug Use Disorder            Perceived Need       Treatment Use  
▪ Any drug    6.7%    13.7%           
▪ Opioid   11.5%     24.1%       
▪ Heroin   25.7%   25.7%          
▪ Rx pain reliever  13.2%     20.6%        
 
Perceived treatment need and utilization changed little from 2008-2010 to 2014-2015 despite the 
implementation of policies intended to increase treatment access over this time period.  
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Methods 
Data.  We conducted analyses of nationally representative data from the National Survey on Drug Use and 
Health (NSDUH) for the years 2008-2015.  The NSDUH is a series of nationally and state-representative 
surveys administered in-person and the primary source of information on substance use behaviors by the U.S. 
household population.  Metropolitan and non-metropolitan status was defined according to U.S. Office of 
Management and Budget definitions.   
We combined several years of data (2008-2010, 2011-2013, and 2014-2015) to achieve adequate sample sizes to 
compare and contrast temporal changes amongst metropolitan and non-metropolitan adults 18-64 years of age.  
These combined years correspond to major substance use treatment policies (implementation of initial parity 
laws in 2008-2010, early insurance expansion in 2011-2013, and clarification of parity laws and further 
insurance expansions in 2014-2015). 
The NSDUH includes structured interviews to illicit Diagnostic and Statistical Manual-IV (DSM-IV) diagnoses 
of illicit drug use disorders.  In this study, we focused on 4 types of past year illicit drug use disorders:  1) any 
type of illicit drug use disorder (illicit refers to the use of illegal drugs, such as heroin, and the misuse of legal 
drugs, such as prescription opioid pain relievers), 2) opioid use disorder (which includes heroin and other types 
of opioid use), 3) heroin use disorder, and 4) prescription pain reliever use disorder (the NSDUH queries about 
prescription pain reliever use, of which the vast majority are opioids).  
We restricted our analyses to persons who satisfied DSM-IV criteria for an illicit drug use disorder in the same 
survey year.  For example, when analyzing perceived need for treatment for any illicit drug use, we limited the 
sample to persons with any past year illicit drug use disorder; when analyzing perceived need for treatment for 
opioid use disorder, we limited the sample to persons with a past year opioid use disorder specifically.  For the 
analyses of persons with heroin and prescription pain reliever use disorders, we combined all years of data 
because of small sample sizes and thus we were not able to conduct analyses of changes over time. 
Dependent Variables.  Perceived need for drug use treatment was defined as self-reported need for the 
treatment of illicit drug use in the past 12 months as measured by answering “yes” to at least one of the 
following questions:  "During the past 12 months, did you feel the need for treatment for your use of (detailed 
drug type)?" and "During the past 12 months, did you feel additional need for treatment for your use of (detailed 
drug type)?"  Drug use treatment utilization was defined as whether the respondent reported receiving treatment 
for any type of illicit drug use in any of the following settings:  hospital inpatient setting, rehabilitation inpatient 
setting, rehabilitation outpatient clinic, and outpatient mental health center.  We also included whether the 
respondent received treatment at a physician clinic for opioid use disorder treatment (both heroin and 
prescription pain medications) as a proxy for buprenorphine medication-assisted treatment (MAT) that is 
usually provided by office-based physicians under the Drug Addiction Treatment Act (DATA) waiver 
mechanism.  We excluded services at an emergency department or self-help group as they would not involve 
intensive treatment; and we excluded services at jail/prison as they could be mandated by the legal system. 
Independent Variables.  Time periods were categorized as 2008-2010, 2011-2013, and 2014-2015.  
Metropolitan and non-metropolitan residence was defined according to U.S. Office of Management and Budget 
definitions.  Demographics included age (18-25, 26-34, 35-49, and 50-64 years), gender, and race/ethnicity 
(Hispanic, black/African American, Asian, other, and non-Hispanic white).  Social characteristics were marital 
status (never married, divorced, widowed, and married) and educational status (< high school graduate, high 
school graduate, some college, and college graduate).  Economic characteristics included employment 
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(unemployed, part-time, other, and full-time employment), household income (< 100%, 100%-200%, and > 
200% of the Federal poverty level), and health insurance (Medicaid, private insurance, other, and none). 
Statistical Analysis.  We conducted descriptive analyses to compare and contrast prevalence rates of perceived 
treatment need and utilization between non-metropolitan and metropolitan adults ages 18-64 who satisfied 
criteria for an illicit drug use disorder.  We then conducted logistic regression analyses to test for metropolitan 
versus non-metropolitan differences in the odds of perceived treatment need and utilization after adjusting for 1) 
demographic characteristics and 2) demographic, social, and economic characteristics.  All analyses accounted 
for NSDUH’s sampling scheme and weights. 
Findings 
Any Illicit Drug and Opioid Use Disorders:  Perceived Treatment Need and Utilization 
As shown in Figure 1, perceived treatment need ranged from a low of 6.7% in 2014-2015 to a high of 11.3% in 
2011-2013 among non-metropolitan residents with any illicit drug use disorder.  These rates did not 
significantly differ by metropolitan status or change over time in unadjusted or adjusted analyses.    
Rates of perceived treatment need did not differ significantly between metropolitan and non-metropolitan 
residents with an opioid use disorder in unadjusted and adjusted analyses.  However, perceived treatment need 
increased significantly (P < .05) between 2008-2010 and 2011-2013 among non-metropolitan adults. 
Figure 1.  Perceived Treatment Need:  Any Illicit Drug and Opioid Use Disorders 
 
 
Figure 2 shows that treatment use ranged between a low of 11.0% in 2011-2013 to a high of 13.7% in 2014-
2015 among non-metropolitan residents with any illicit drug use disorder.  Past year treatment rates for any 
illicit drug use disorder did not significantly differ by metropolitan status in unadjusted or adjusted analyses.  
Treatment use increased significantly from 2008-2010 to 2011-2013 among metropolitan residents when 
adjusting for other factors.   
Treatment use rates were higher among persons with an opioid use disorder.  Metropolitan residents had 
significantly higher adjusted and unadjusted treatment rates than non-metropolitan residents during 2011-2013 
only.  Treatment rates increased significantly among metropolitan residents between periods 2008-2010 and 
2011-2013 and among non-metropolitan residents between 2011-2013 and 2014-2015. 
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Figure 2.  Treatment Use:  Any Illicit Drug and Opioid Use Disorders 
 
Heroin and Prescription Pain Reliever Use Disorders:  Perceived Treatment Need and Utilization 
Again, we did not conduct analyses of temporal changes in perceived treatment need and utilization among 
adults with a heroin or prescription pain reliever use disorder because of small sample size limitations.  
Therefore, estimates reported in Figures 3 and 4 are from 2008-2015 combined NSDUH data.  As shown in 
Figure 3, perceived treatment need did not differ significantly in unadjusted and adjusted analyses between 
metropolitan and non-metropolitan residents with a heroin use disorder.  However, perceived treatment need 
was higher among non-metropolitan than metropolitan residents with a prescription pain reliever use disorder 
in unadjusted and adjusted analyses.  
 
Figure 3.  Perceived Treatment Need:  Heroin and Prescription Pain Reliever Use Disorders 
 
 
Figure 4 shows population-weighted rates of any treatment use among persons satisfying criteria for heroin and 
prescription pain reliever use disorders.  Treatment rates were significantly higher among metropolitan than 
non-metropolitan residents with a heroin use disorder in unadjusted and adjusted analyses.  Treatment rates 
were comparably lower among persons with a prescription pain reliever use disorder and did not significantly 
differ by metropolitan status. 
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Figure 4.  Treatment Utilization:  Heroin and Prescription Pain Reliever Use Disorders 
 
Conclusion and Potential Policy Implications 
Perceiving a need for treatment is considered an essential first step in the treatment-seeking process and has 
been shown to be strongly associated with treatment utilization.3-5  The findings presented in this brief indicate 
that the vast majority of non-metropolitan adults ages 18-64 who satisfy criteria for an illicit drug use disorder 
do not perceive that they need treatment and do not receive any formal treatment services.  Despite several 
health policies aimed at increasing access to substance use treatment services over the study period, including 
implementation of initial parity laws in 2008-2010, early insurance expansion in 2011-2013, and clarification of 
parity laws and further insurance expansions in 2014-2015, our study found very few changes over time in 
perceived treatment need and utilization.   Potential policy issues emerging from our research include: 
1) The need to stimulate positive perceptions about treatment need among illicit drug users and their families 
and friends.  Because perceived need is strongly associated with the decision to seek treatment, efforts to 
promote the benefits of treatment could facilitate actual treatment utilization.7,8  
2) The importance of screening, brief intervention, and referral to treatment (SBIRT) in rural primary care.  
SBIRT has been shown to be an effective means of identifying persons with drug use problems,9,10 but many 
rural primary care providers may need assistance linking patients who screen positive for illicit drug or 
prescription pain reliever use problems to outpatient or residential drug use treatment.   
3) Capacity limits of rural-serving outpatient and residential treatment programs.  Substance use treatment 
organizations and providers may need incentives to serve non-metropolitan market areas. 
4) Limited supply of behavioral health providers serving rural areas, including psychiatrists, clinical 
psychologists, social workers, and psychiatric nurse practitioners.  Prior research has shown that all of these 
providers are less available in non-metropolitan counties.11  Increasing the supply of behavioral health 
counselors could also help assure that persons with opioid use disorders receiving buprenorphine as part of 
Medication-Assisted Treatment also receive psychosocial treatment (e.g., assessment of psychosocial needs, 
counseling or cognitive behavioral therapy, and referrals to community social services).12 
5) Providers’ caps on the number of buprenorphine-prescribed patients.  The Federal government recently 
raised the cap from 100 to 275 patients, but prior research suggests buprenorphine utilization (for opioid use 
disorders) is more strongly associated with increases in patient caps than increases in physicians prescribing 
buprenorphine.13 
48.6 
25.7 
19.5 20.6 
0 
10 
20 
30 
40 
50 
60 
Metro Non-Metro Metro Non-Metro 
Heroin Use Disorder Prescription Pain Reliever Use Disorder 
Treatment Use 
% 
Perceived Treatment Need and Use  Policy Brief 
 
Rural & Underserved Health Research Center Page 6 
References  
1. Borders TF, Wen H. Illicit Drug and Opioid Use Disorders among Non-Metropolitan Residents Nationally. 
Lexington, KY:  Rural and Underserved Health Research Center; 2018.  
2. Borders TF, Booth BM. Research on rural residence and access to drug abuse services: where are we and 
where do we go? J Rural Health. 2007;23(s1):79-83. 
3. Edlund MJ, Unutzer J, Curran GM. Perceived need for alcohol, drug, and mental health treatment. Soc 
Psychiatry Psychiatr Epidemiol. 2006;41(6):480-487. 
4. Falck RS, Wang J, Carlson RG, Krishnan LL, Leukefeld C, Booth BM. Perceived need for substance abuse 
treatment among illicit stimulant users in rural areas of Ohio, Arkansas, and Kentucky. Drug Alcohol 
Depend. 2007;91:107-114. 
5. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or 
substance use disorders. Arch Gen Psychiatry. 2002;59(1):77-84. 
6. Ali MM, Teich JL, Mutter R. The role of perceived need and health insurance in substance use treatment: 
implications for the Affordable Care Act. J Subst Abuse Treat. 2015;54:14-20. 
7. Borders TF, Booth BM, Stewart KE, Cheney AM, Curran GM. Rural/urban residence, access, and perceived 
need for treatment among African American cocaine users. J Rural Health. 2015;31(1):98-107. 
8. Edlund MJ. Perceived need for treatment for alcohol use disorders: Results from two national surveys. 
Psychiatr Serv. 2009;60(12):1618-1628. 
9. Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and 
Referral to Treatment (SBIRT) toward a public health approach to the management of substance abuse. 
Subst Abus. 2007;28(3):7-30. 
10. Ghitza UE, Tai B. Challenges and opportunities for integrating preventive substance-use-care services in 
primary care through the Affordable Care Act. J Health Care Poor Underserved. 2014;25(1 0):36. 
11. Larson EH, Patterson DG, Garberson LA, Andrilla CHA. Suppy and Distribution of the Behavioral Health 
Workforce in Rural America. Data Brief #160. Seattle, WA: WWAMI Rural Health Research Center, 
University of Washington; 2016 Sep 1.  
12. Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the 
Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2015;9(5):358-367. 
13. Stein BD, Pacula RL, Gordon AJ, et al. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? 
The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban 
and Rural Counties. Milbank Q. 2015;93(3):561-583. 
 
Acknowledgments 
We thank Julia Cecil, MA, MBA, for her managerial and editorial assistance.  
 
Contact Information 
Ty Borders, PhD, Director, Rural and Underserved Health Research Center   
email: ty.borders@uky.edu                         website:  http://ruhrc.uky.edu 
 
Suggested Citation 
Borders TF, Wen H.  Perceived Treatment Need and Utilization for Illicit Drug and Opioid Use Disorders in 
Non-Metropolitan Areas.  Lexington, KY:  Rural and Underserved Health Research Center; 2018. 
